Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Affimed Ord Shs (NQ: AFMD )

5.100 +0.030 (+0.59%)
Streaming Delayed Price Updated: 3:35 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 58,048
Open 5.130
Bid (Size) 5.050 (4)
Ask (Size) 5.110 (2)
Prev. Close 5.070
Today's Range 5.000 - 5.210
52wk Range 0.2235 - 7.240
Shares Outstanding 15,227,463
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AFMD Stock Earnings: Affimed Beats EPS, Misses Revenue for Q4 2023
AFMD stock results show that Affimed beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Affimed Reports 2023 Financial Results and Operational Progress
From Affimed N.V.
Via GlobeNewswire

Performance

YTD
+716.00%
+716.00%
1 Month
N/A
N/A
3 Month
+745.35%
+745.35%
6 Month
+1311.18%
+1311.18%
1 Year
+518.18%
+518.18%

More News

Read More
Earnings Scheduled For March 28, 2024
Via Benzinga
A Preview Of Affimed's Earnings
Via Benzinga
Recap: Affimed Q3 Earnings
Via Benzinga
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
From Affimed N.V.
Via GlobeNewswire
ASTR Stock Alert: Astra Space Is Going Private
Via InvestorPlace
Why Is AerSale (ASLE) Stock Down 18% Today?
Via InvestorPlace
Why Is Affimed (AFMD) Stock Moving Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Earnings Outlook For Affimed
Via Benzinga
7 of the Best Speculative Stocks You Can Snag for Less Than $1
Via InvestorPlace
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Affimed Announces 1-for-10 Reverse Stock Split
From Affimed N.V.
Via GlobeNewswire
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Leadership Change and Organizational Restructuring
From Affimed N.V.
Via GlobeNewswire
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
From Affimed N.V.
Via GlobeNewswire
3 Penny Stocks That Are Too Compelling to Ignore
Via InvestorPlace
Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients
From Affimed N.V.
Via GlobeNewswire
Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
From Affimed N.V.
Via GlobeNewswire
Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
From Affimed N.V.
Via GlobeNewswire
Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
From Affimed N.V.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.